Drugs / Extended release niacin
last change Dec 2012 re-read 3 minutes ago

Extended release niacin

Developed for
chronic kidney disease · hyperlipidemia

Trials 0

PhaseRegistry idDatesIndicationSponsorStatusOutcome
Comparator or background therapy1 trial
Phase 3 NCT00108485 Comparator Apr 2005 → Dec 2012 chronic kidney disease, hyperlipidemia, type 2 diabetes mellitus University of Miami Terminated No outcome recorded Stop: Enrollment

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Extended release niacin ClinicalTrials.gov intervention name — accepted as the source's own label NCT00108485 ↗